
|Articles|March 10, 2008
Clinical twisters: Addressing CVA prophylaxis
This case study assesses the need for anticoagulation and the drugs of choice for prophylaxis against cerebrovascular accidents (strokes) in patients with previous CVAs of different origins.
Advertisement
Nancy L. Shapiro, Pharm.D., BCPSAimee Chevalier, Pharm.D.
Clinical Pharmacists, Antithrombosis Clinic
Clinical Assistant Professor, Dept. of Pharmacy Practice
University of Illinois at Chicago College of Pharmacy
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5







































